Walleye Trading
EDIT icon

Walleye Trading’s Editas Medicine EDIT Stock Holding History

Walleye Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,400
Closed -$9.02K – 4270
2025
Q4 		$9.02K Buy
4,400
+200
+5% +$577 ﹤0.01% 4166
2025
Q3 		$14.6K Buy
+4,200
New +$11.7K ﹤0.01% 4176
2024
Q1 		– Sell
-100
Closed -$1.01K – 4895
2023
Q4 		$1.01K Buy
+100
New +$878 ﹤0.01% 4913
2023
Q3 		– Sell
-5,800
Closed -$47.7K – 5065
2023
Q2 		$47.7K Sell
5,800
-60,200
-91% -$524K ﹤0.01% 3972
2023
Q1 		$479K Sell
66,000
-20,300
-24% -$180K ﹤0.01% 2839
2022
Q4 		$765K Buy
86,300
+18,500
+27% +$203K ﹤0.01% 2455
2022
Q3 		$830K Sell
67,800
-7,400
-10% -$115K ﹤0.01% 2408
2022
Q2 		$890K Sell
75,200
-59,700
-44% -$800K ﹤0.01% 2344
2022
Q1 		$2.57M Buy
134,900
+63,500
+89% +$1.18M 0.01% 1486
2021
Q4 		$1.9M Buy
71,400
+35,400
+98% +$1.22M 0.01% 1690
2021
Q3 		$1.48M Buy
36,000
+33,300
+1,233% +$1.82M 0.01% 1843
2021
Q2 		$153K Buy
2,700
+400
+17% +$14.8K ﹤0.01% 4129
2021
Q1 		$97K Buy
2,300
+1,200
+109% +$68.4K ﹤0.01% 4109
2020
Q4 		$77K Sell
1,100
-4,900
-82% -$201K ﹤0.01% 4036
2020
Q3 		$168K Buy
6,000
+5,900
+5,900% +$192K ﹤0.01% 3110
2020
Q2 		$3K Sell
100
-7,100
-99% -$186K ﹤0.01% 4145
2020
Q1 		$143K Sell
7,200
-3,200
-31% -$80.7K ﹤0.01% 2876
2019
Q4 		$308K Sell
10,400
-1,900
-15% -$47.5K ﹤0.01% 2797
2019
Q3 		$280K Buy
12,300
+400
+3% +$9.91K ﹤0.01% 2654
2019
Q2 		$294K Buy
11,900
+4,700
+65% +$112K ﹤0.01% 2629
2019
Q1 		$176K Sell
7,200
-44,700
-86% -$1.01M ﹤0.01% 3131
2018
Q4 		$1.18M Buy
51,900
+28,700
+124% +$781K 0.01% 1541
2018
Q3 		$738K Sell
23,200
-4,800
-17% -$155K ﹤0.01% 2444
2018
Q2 		$1M Sell
28,000
-4,500
-14% -$159K 0.01% 2100
2018
Q1 		$1.08M Buy
+32,500
New +$1.16M 0.01% 1841

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Walleye Trading's EDIT Position: Q1 2024 in Review

Walleye Trading sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 29,828 shares — an estimated $302K sold.

Walleye Trading first reported a position in EDIT in Q1 2018 and held it in 18 quarters. The position peaked at $1.56M in Q2 2021. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Walleye Trading reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 29,828 Editas Medicine shares in Q1 2024, an estimated $302K.
  • Walleye Trading first reported a position in Editas Medicine in Q1 2018 and held it in 18 quarters.
  • Walleye Trading's Editas Medicine position peaked at $1.56M in Q2 2021.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.